Email this article 
The “Signicef” ® use for prevention of postoperative infectious complications
- Authors: Nikolaenko V.P.1, Kataeva M.V.1, Panova T.Y.1
-
Affiliations:
- City Ophthalmologic Center of City hospital N 2
- Issue: Vol 7, No 4 (2014)
- Pages: 63-66
- Section: Articles
- URL: https://journals.eco-vector.com/ov/article/view/389
- DOI: https://doi.org/10.17816/OV2014463-66
- ID: 389
Cite item
Full Text
Abstract
Purpose. To study the efficacy and the tolerability of “Signicef” when used during the early post-operative period after ophthalmic surgeries. Materials and methods. The treatment group consisted of 82 patients, in whom ophthalmic surgeries were performed. All patients received treatment of antibiotics and anti-inflammatory medications according to standard pattern that included instillations of “Signicef” eye drops. The anterior segment of the operated eye was examined every day until discharge from the hospital, as well as after 7 and 14 days after surgery. Results. There were no cases of purulent complications among the study group. No objective signs of infection or drug intolerance were observed. Conclusions. “Signicef” ensured an adequate prevention of infectious complications at early postoperative period and demonstrated a good tolerability in patients of the study group.
About the authors
Vadim Petrovich Nikolaenko
City Ophthalmologic Center of City hospital N 2
Email: dr.Nikolaenko@mail.ru
MD, doctor of medical science, head of ophthalmology center
Mariya Valer'yevna Kataeva
City Ophthalmologic Center of City hospital N 2
Email: mvkatae8a@gmail.com
ophthalmologist
Tat'yana Yur'yevna Panova
City Ophthalmologic Center of City hospital N 2
Email: Aurinko89@rambler.ru
ophthalmologist
References
- Астахов С. Ю., Вохмяков А. В. Офтальмологические фторхинолоны в лечении и профилактике глазных инфекций (обзор литературы). Клиническая офтальмология, 2008; 9 (8): 28-30.
- Инструкция по применению препарата «Сигницеф»®.
- Околов И. Н., Гурченок П. А., Вохмяков А. В. Резистентность коагулазонегативных стафилококков, выделенных у больных с конъюнктивитами и послеоперационными эндофтальмитами к антибактериальным препаратам. Материалы VII Съезда офтальмологов Республики Беларусь. Минск, 2007; 452-457.
- Эббот Р. Л. Десять наиболее важных моментов для предупреждения эндофтальмита. Белые ночи: материалы XV Юбилейного международного офтальмологического конгресса (V Конгресса Международной ассоциации врачей-офтальмологов). Санкт-Петербург, 2009; 1-8.
- Barry P., Behrens-Baumann W., Pleyer U., Seal D. (Ed.) ESCRS Guidelines on prevention, investigation and management of post-operative endophthalmitis. Version 2, 2007; 9-12.
- Chang D. F., Braga-Mele R., Mamalis N. et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J. Cataract Refract. Surg, 2007; 33 (10): 1801-1805.
- McDonald M. B., Quintiliani R., Asbell P. A. Antimicrobial Susceptibility: Nationwide patterns in the TRUST surveillance program. Perspectives from specialists in ophthalmology, microbiology, and infectious disease. Ophthalmology Times, 2006; 31 (9): 1-S.12.
Supplementary files
